4.0
May 27, 2026
Former employee, more than 10 years
South San Francisco, CA
Recommend
CEO approval
Business Outlook
Pros
Was a great situation, busy with work.
Cons
The past couple of years, lots of changes, downsizing, reorganization, even before I left, the company lost a lot of great, knowledgeable people. The company itself has changed a lot. I think it's more focused now on acquiring other smaller biotech/AI firms than on research, following the same business model, I guess, as other competitors. Sold their other site in Vacaville to a good CMO manufacturing company, I believe Lonza?